Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Actas Espanolas De Psiquiatria|October 21, 2025
The Promise of Long-acting Injectable Antipsychotics for the Treatment of Bipolar I Disorder: The Role of Manic PredominanceDaniele Cavaleri, Ilaria Riboldi, Francesco BartoliJournal of Clinical Medicine|January 26, 2024
The Kynurenine Pathway in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Blood Concentrations of Tryptophan and Its CatabolitesDaniele Cavaleri, Cristina Crocamo, Pietro Morello, et al.Schizophrenia Research|June 19, 2026
Complete blood count-derived inflammatory markers and symptom phenotypes in schizophrenia spectrum disorders: A hierarchical clustering analysisDaniele Cavaleri, Cristina Crocamo, Giorgio Cucchi, et al.Psychology Research and Behavior Management|June 23, 2025
Clinical Utility of Long-Acting Injectable Risperidone in Schizophrenia and Bipolar I Disorder: A Review of Clinical StudiesFrancesco Bartoli, Daniele Cavaleri, Ilaria Riboldi, et al.Neuroscience Letters|April 26, 2024
Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamineDaniele Cavaleri, Ilaria Riboldi, Cristina Crocamo, et al.Therapeutic Advances in Psychopharmacology|November 3, 2025
Clinical and biochemical factors associated with hyperammonemia in inpatients with mental disorders treated with valproic acid: a cross-sectional analysisIlaria Riboldi, Daniele Cavaleri, Marco Morreale, et al.European Archives of Psychiatry and Clinical Neuroscience|November 4, 2025
Complete blood count-based inflammation indexes and symptom severity in people with bipolar disorder: an analysis based on structural equation modellingDaniele Cavaleri, Cristina Crocamo, Ilaria Riboldi, et al.Psychology Research and Behavior Management|January 6, 2023
Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of SchizophreniaIlaria Riboldi, Daniele Cavaleri, Chiara A Capogrosso, et al.Psychoneuroendocrinology|July 26, 2024
Complete blood count-based inflammation indexes and symptom severity in people with schizophrenia spectrum disorders: An analysis based on structural equation modellingDaniele Cavaleri, Aldo De Pietra, Marco Gazzola, et al.Journal of Psychiatric Research|September 11, 2021
Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trialsFrancesco Bartoli, Daniele Cavaleri, Bianca Bachi, et al.Pageof 4